Inspire Medical (INSP) | Stock Overview & Key Data
Inspire Medical Performance Comparison
Stock Range
Today's Range
Low: $78.82
High: $84.17
on August 12, 2025
52 Week Range
Low: $73.92
High: $225.00
on August 5, 2025
on September 9, 2024
All-Time High: $330.00 on July 10, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.3B
EPS
1.74
P/E Ratio (TTM)
45.48
Forward P/E
39.97
P/B Ratio
3.45
PEG Ratio
39.97
Div. Yield
N/A
ROE
8.07%
Beta
1.220
Debt to Equity
4.88
Financial Highlights
Profitability
Gross Margin
84.03%
Operating Margin
-1.53%
Profit Margin
6.17%
Returns and Earnings
Return on Assets (TTM)
3.38%
Return on Equity (TTM)
8.07%
EBITDA
$75.6M
Net Income (TTM)
$53.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$28.96
Quarterly Revenue Growth (YoY)
10.80%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Inspire Medical INSP | 2.34B Mid-cap | -4.53% | -35.57% | -46.35% | -55.12% | -55.64% | -57.81% | -62.99% | -28.46% |
| Abbott Laboratories ABT | 233.71B Mega-cap | 0.25% | -0.76% | -0.73% | 0.41% | 15.50% | 18.04% | 19.04% | 27.95% |
| Boston Scientific BSX | 152.83B Large-cap | -2.09% | -1.62% | -0.22% | -2.96% | 14.84% | 31.17% | 144.26% | 167.08% |
| Penumbra PEN | 9.38B Mid-cap | 3.52% | 3.86% | -16.47% | -6.93% | 3.57% | 25.72% | 47.41% | 2.94% |
| Globus Medical GMED | 7.92B Mid-cap | 15.34% | 7.84% | 4.85% | -26.35% | -24.39% | -14.93% | -8.29% | 11.23% |
| Masimo MASI | 7.86B Mid-cap | -8.39% | -7.15% | -8.21% | -16.37% | -10.94% | 19.40% | -5.36% | -32.77% |
Ownership & Short Interest
Insider Ownership
1.11%
Institutional Ownership
118.69%
Shares Short
3M
Short Ratio
5.52
Short % of Shares Outstanding
15.00%
Average 10-Day Volume
2M
Average 90-Day Volume
1M
Inspire Medical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Inspire Medical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INSP's 52-week high and low?
- In the last 52 weeks, Inspire Medical reached a high of $225.00 (on September 9, 2024) and a low of $73.92 (on August 5, 2025).
- What is the market cap and P/E ratio for INSP?
- Curious about Inspire Medical's size and valuation? Its market capitalization stands at 2.34B. When it comes to valuation, the P/E ratio (trailing twelve months) is 45.48, and the forward P/E (looking ahead) is 39.97.
- Does INSP pay dividends? If so, what's the yield?
- As for dividends, Inspire Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Inspire Medical's main competitors or similar companies to consider before investing?
When looking at Inspire Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT233.71B Healthcare Medical Devices 18.04% 19.04% Boston Scientific
BSX152.83B Healthcare Medical Devices 31.17% 144.26% Penumbra
PEN9.38B Healthcare Medical Devices 25.72% 47.41% Globus Medical
GMED7.92B Healthcare Medical Devices -14.93% -8.29% Masimo
MASI7.86B Healthcare Medical Devices 19.40% -5.36% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Inspire Medical Systems, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Inspire Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.07%, the Debt to Equity ratio from the most recent quarter is 4.88, and its Gross Profit Margin stands at 84.03%.
- What is the recent revenue and earnings growth for INSP?
- Looking at Inspire Medical's growth, its revenue over the trailing twelve months (TTM) was $861M. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.80%, and quarterly earnings saw a YoY growth of N/A.
- How much of INSP stock is held by insiders and institutions?
- Wondering who owns Inspire Medical stock? Company insiders (like executives and directors) hold about 1.11% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 118.69%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.